[go: up one dir, main page]

AR018335A1 - Compuesto carbapenico, agente antibacteriano que lo comprende y compuesto carbapenico util como intermediario para la obtencion del primero - Google Patents

Compuesto carbapenico, agente antibacteriano que lo comprende y compuesto carbapenico util como intermediario para la obtencion del primero

Info

Publication number
AR018335A1
AR018335A1 ARP990102033A ARP990102033A AR018335A1 AR 018335 A1 AR018335 A1 AR 018335A1 AR P990102033 A ARP990102033 A AR P990102033A AR P990102033 A ARP990102033 A AR P990102033A AR 018335 A1 AR018335 A1 AR 018335A1
Authority
AR
Argentina
Prior art keywords
compound
carbapenic
useful
obtaining
antibacterial agent
Prior art date
Application number
ARP990102033A
Other languages
English (en)
Original Assignee
Kyoto Pharma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10122499A external-priority patent/JP2000344772A/ja
Priority claimed from JP10203730A external-priority patent/JP2000344773A/ja
Application filed by Kyoto Pharma Ind filed Critical Kyoto Pharma Ind
Publication of AR018335A1 publication Critical patent/AR018335A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un compuesto carbapénico de formula (I) en donde R1 es un modificador hidrolizable en el organismo vivo; R2 y R3 son iguales o diferentes y cadauno es un alquilo C1-6; R es un grupo de formula (B) o de formula (C). Un agente antibacteriano que comprende dicho compuesto carbapénico comoingrediente activo. Este compuesto carbapénico es superior en absorcion por parte del tracto digestivo al ser administrado por vía oral y exhibesuficiente poder antibacteriano frente a una amplia gama de especies bacterianas. Por ende, el compuesto es sumamente util para la profilaxisy tratamiento de enfermedades infecciosas (particularmente infecciones bacterianas). Se describe, además, un compuesto carbapénico util como intermediariopara la obtencion del anterior.
ARP990102033A 1998-05-01 1999-04-30 Compuesto carbapenico, agente antibacteriano que lo comprende y compuesto carbapenico util como intermediario para la obtencion del primero AR018335A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10122499A JP2000344772A (ja) 1998-05-01 1998-05-01 カルバペネム誘導体、その用途およびその中間体化合物
JP10203730A JP2000344773A (ja) 1998-07-17 1998-07-17 カルバペネム誘導体、およびその用途並びにその中間体化合物

Publications (1)

Publication Number Publication Date
AR018335A1 true AR018335A1 (es) 2001-11-14

Family

ID=26459604

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102033A AR018335A1 (es) 1998-05-01 1999-04-30 Compuesto carbapenico, agente antibacteriano que lo comprende y compuesto carbapenico util como intermediario para la obtencion del primero

Country Status (24)

Country Link
US (1) US6410525B1 (es)
EP (1) EP1078927B1 (es)
KR (1) KR100589030B1 (es)
CN (1) CN1163494C (es)
AR (1) AR018335A1 (es)
AT (1) ATE337321T1 (es)
AU (1) AU760386B2 (es)
BG (1) BG105004A (es)
BR (1) BR9910098A (es)
CA (1) CA2330641A1 (es)
CO (1) CO5011051A1 (es)
CZ (1) CZ292623B6 (es)
DE (1) DE69932927D1 (es)
HU (1) HUP0101735A3 (es)
ID (1) ID27081A (es)
NO (1) NO20005480L (es)
NZ (1) NZ508493A (es)
PL (1) PL343728A1 (es)
RU (1) RU2222540C2 (es)
SK (1) SK16382000A3 (es)
TR (1) TR200003199T2 (es)
TW (1) TW528750B (es)
WO (1) WO1999057121A1 (es)
YU (1) YU66700A (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0112580A (pt) 2000-07-19 2003-06-17 Hoffmann La Roche Compostos, composições farmacêuticas que contêm os mesmos, utilização desses compostos, processo para tratamento terapêutico e/ou profilático e processo para a preparação desses compostos
HUP0400444A3 (en) * 2001-05-21 2007-02-28 Kyoto Pharmaceutical Ind Carbapenem compound, pharmaceutical compositions containing them and their use
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
CA2465336C (en) 2001-11-05 2009-04-28 Sumitomo Pharmaceuticals Co., Ltd. Novel carbapenem compounds
US7468364B2 (en) 2003-04-08 2008-12-23 Dainippon Sumitomo Pharma Co., Ltd. Carbapenem compounds
EP1785426A4 (en) * 2004-09-03 2008-02-20 Dainippon Sumitomo Pharma Co NEW CARBAPENEM DERIVATIVE
US20090029964A1 (en) * 2005-03-25 2009-01-29 Makoto Sunagawa Novel carbapenem compound
KR20080041722A (ko) * 2005-08-31 2008-05-13 와이어쓰 글리실사이클린의 9-아미노카르보닐 치환된 유도체
CN101376656A (zh) * 2007-08-30 2009-03-04 山东轩竹医药科技有限公司 培南衍生物
US9725451B2 (en) 2013-03-15 2017-08-08 Kala Pharmaceuticals, Inc. Meropenem derivatives and uses thereof
CA3114618C (en) * 2018-10-01 2023-09-05 Arixa Pharmaceuticals, Inc. Derivatives of relebactam and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
US4539332A (en) * 1983-11-14 1985-09-03 Merck & Co., Inc. 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
JPS60233076A (ja) 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
JPS61275279A (ja) 1984-12-25 1986-12-05 Sankyo Co Ltd カルバペネム化合物
IE60588B1 (en) 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
FI91258C (fi) 1988-04-01 1994-06-10 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten 2-(heterosyklyylitio)karbapeneemijohdannaisten valmistamiseksi
US5242914A (en) 1988-04-01 1993-09-07 Sankyo Company, Limited 2-(heterocyclylthio) carbapenem derivatives, their preparation and their use as antibiotics
IE910606A1 (en) * 1990-02-23 1991-08-28 Sankyo Co Carbapenem derivatives having antibiotic activity, their¹preparation and their use
AU644008B2 (en) 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
US5712267A (en) 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
JP3048196B2 (ja) * 1991-06-20 2000-06-05 第一製薬株式会社 カルバペネム誘導体
US5360798A (en) 1991-07-04 1994-11-01 Shionogi Seiyaku Kabushiki Kaisha Aminooxypyrrolidinylthiocarbapenem compounds
EP0882728B1 (en) 1995-12-21 2002-09-04 Sankyo Company Limited 1-methylcarbapenem derivatives

Also Published As

Publication number Publication date
NZ508493A (en) 2002-06-28
NO20005480L (no) 2000-12-20
AU3627299A (en) 1999-11-23
EP1078927A4 (en) 2003-01-08
CN1163494C (zh) 2004-08-25
CZ292623B6 (cs) 2003-11-12
BR9910098A (pt) 2000-12-26
NO20005480D0 (no) 2000-10-31
TW528750B (en) 2003-04-21
CZ20003954A3 (cs) 2001-04-11
HUP0101735A2 (hu) 2001-12-28
CO5011051A1 (es) 2001-02-28
KR20010043196A (ko) 2001-05-25
ID27081A (id) 2001-02-22
KR100589030B1 (ko) 2006-06-13
AU760386B2 (en) 2003-05-15
ATE337321T1 (de) 2006-09-15
CA2330641A1 (en) 1999-11-11
HUP0101735A3 (en) 2002-02-28
TR200003199T2 (tr) 2001-03-21
EP1078927A1 (en) 2001-02-28
EP1078927B1 (en) 2006-08-23
US6410525B1 (en) 2002-06-25
PL343728A1 (en) 2001-09-10
RU2222540C2 (ru) 2004-01-27
SK16382000A3 (sk) 2001-05-10
YU66700A (sh) 2003-01-31
BG105004A (en) 2001-08-31
CN1307578A (zh) 2001-08-08
WO1999057121A1 (en) 1999-11-11
DE69932927D1 (de) 2006-10-05

Similar Documents

Publication Publication Date Title
AR018335A1 (es) Compuesto carbapenico, agente antibacteriano que lo comprende y compuesto carbapenico util como intermediario para la obtencion del primero
KR100437566B1 (ko) 알콜, 클로르헥시딘 및 유기산을 포함하는 소독용 조성물
EP2723342B1 (de) Verwendung von 10h-benzo[g]pteridin-2,4-dion-derivaten
BG106825A (en) Substituted oxazolidinones and their use in the field of blood coagulation
JP2005511642A5 (es)
BR0113861A (pt) Derivados de ácidos 3-(heteroaril acetamido)-2-oxo-azetidina-1-sulfÈnicos como agentes antibacterianos
Modak et al. Sulfadiazine silver-resistant Pseudomonas in burns: new topical agents
ATE232862T1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
ATE294185T1 (de) Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediäre zur herstellung der derivate
ATE250054T1 (de) Oxazolidinone derivate und pharmazeutische zusammensetzungen
BG108498A (en) New derivatives of oxazolidinones as antibacterial agents
CA2430967A1 (en) Remedies for bone marrow suppression and infectious diseases and white blood cell count elevating agents
FI933681A0 (fi) Antimikrobiellt medel
BRPI0413413A (pt) feniloxazolidinonas de piperidino substituìdo tendo atividade antimicrobiana com eficácia in vivo melhorada
HRP20030907B1 (hr) Farmaceutska kompozicija na bazi makrolida za lokalnu upotrebu u oftalmologiji
CA3242451A1 (en) An injectable pharmaceutical composition for the treatment of respiratory diseases in animals
DE60030300D1 (de) Topische behandlung zur vorbeugung von augeninfektionen
BR0209970A (pt) Composto de carbapenem
JP2002302404A (ja) 抗菌防黴助剤
Bezhuk et al. Effectiveness of using domestic quaternary ammonium antiseptic in general medicine and dentistry (modern view and clinical case)
EP0740940A3 (en) Process for disinfecting musculoskeletal tissue and tissues prepared thereby
PT1059845E (pt) Composicao fungicida compreendendo uma benzoilfenilureia
WO1995033463A2 (en) Synergistic antibiotic compositions containing a perphyrin and an antibiotic
AR005730A1 (es) Forma de fanciclovir, procedimiento para prepararla, composiciones farmaceuticas que la contienen y metodo para el tratamiento o profilaxis deinfecciones virales y el uso de dicha forma -fanciclovir monoidrato.
JP2002284604A (ja) 抗菌防黴助剤

Legal Events

Date Code Title Description
FA Abandonment or withdrawal